Bio2Vec

BIO-KNOWLEDGE-GRAPH

A knowledge graph of biological entities such as genes, gene functions, diseases, phenotypes and chemicals. Embeddings are generated with Walking RDF and OWL method.

Impaired von Willibrand factor collagen binding activity

ID: HP:0030130

Type: http://bio2vec.net/ontology/phenotype

Label: Impaired von Willibrand factor collagen binding activity

Synonyms: Impaired von Willibrand factor collagen binding activity

Alternative IDs: als

API: GO

SPARQL: GO

Similar Entities

Impaired von Willibrand factor collagen binding activity

HP:0030130
Total absence von Willebrand factor multimers

HP:0030134
Absence of intermediate von Willibrand factor multimers

HP:0030135
Abnormal von Willebrand factor multimer distribution

HP:0030131
Enhanced ristocetin cofactor assay activity

HP:0030136
Absence of large von Willibrand factor multimers

HP:0030132
Reduced von Willebrand factor activity

HP:0008330
Impaired binding of factor VIII to VWF

HP:0040237
Decreased level of plasminogen

HP:0040228
Impaired ristocetin cofactor assay activity

HP:0030129
Increased ratio of VWF propeptide to VWF antigen

HP:0040240
Abnormal presence of ultra-large von Willebrand factor multimers

HP:0030133
Increased plasma vitamin K epoxide after vitamin K supplementation

HP:0040239
Decrease in high molecular weight von Willebrand factor Multimers

HP:0040225
Decreased level of histidine-rich glycoprotein

HP:0040227
Abnormality of von Willebrand factor

HP:0012146
Decreased level of tissue plasminogen activator

HP:0040230
Reduced quantity of Von Willebrand factor

HP:0012147
Factor XIII subunit A deficiency

HP:0040233
Impaired ristocetin-induced platelet aggregation

HP:0011871
Factor XIII subunit B deficiency

HP:0040234
Hyperfibrinolysis

HP:0040236
Reduced prothrombin consumption

HP:0003337
Decreased level of thrombomodulin

HP:0040229
Elevated factor V activity

HP:0011996
Reduced antithrombin III activity

HP:0001976
Factor X activation deficiency

HP:0008354
Decreased level of heparin co-factor II

HP:0040226
Hyperfibrinogenemia

HP:0011899
Dysfibrinogenemia

HP:0011901
Reduced factor VIII activity

HP:0003125
Resistance to activated protein C

HP:0012175
Abnormality of fibrinolysis

HP:0040224
Reduced factor IX activity

HP:0011858
Hypofibrinogenemia

HP:0011900
obsolete hydrolase activity

GO:0016816
positive regulation of decapentaplegic signaling pathway

GO:0090098
regulation of toll-like receptor 1 signaling pathway

GO:0034131
Reduced factor V activity

HP:0003225
neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress

GO:0036483
regulation of decapentaplegic signaling pathway

GO:0090097
Premature epimetaphyseal fusion in hand

HP:0012562
cholate-CoA ligase activity

GO:0047747
Brown pigment gallstones

HP:0011983
Episodic generalized hypotonia

HP:0006852
Delayed onset bleeding

HP:0040232
no_name

GO:0042513
cetraxate benzylesterase activity

GO:0047741
Reduced prothrombin antigen

HP:0040250
regulation of B cell antigen processing and presentation

GO:0002622
obsolete cytoplasmic dynein light chain

GO:0001690
regulation of CD4-positive

GO:0032829
Abnormal marginal zone B cell count

HP:0030383
positive regulation of protein localization to cell cortex

GO:1904778
Abnormal onset of bleeding

HP:0040231
Reduced factor XI activity

HP:0001929
Hypopnea

HP:0040213
Reduced factor XII activity

HP:0004841
Reduced euglobulin clot lysis time

HP:0040247
Generalized neonatal hypotonia

HP:0008935
positive regulation of transcription from RNA polymerase II promoter in response to superoxide

GO:1990096
His-Purkinje system cell fate commitment

GO:0060934
regulation of protein localization to cell cortex

GO:1904776
Reduced factor XIII activity

HP:0008357
Fetal-maternal hemorrhage affecting management of mother

DOID:12058
Labial pseudohypertrophy

HP:0008739
poliovirus type II nonparalytic poliomyelitis

DOID:10980
Grade II preterm intraventricular hemorrhage

HP:0030749
Decreased activity of the pyruvate dehydrogenase complex

HP:0002928
phosphonopyruvate decarboxylase activity

GO:0033980
Decreased marginal zone B cell count

HP:0030384
Increased marginal zone B cell count

HP:0030385
disorganized type schizophrenia chronic state

DOID:13484
obsolete smooth muscle fiber development

GO:0048746
Decreased memory B cell count

HP:0030374
obsolete lactose hydrolysis

GO:0019514
mesonephric interstitial fibroblast fate commitment

GO:0061268
regulation of nuclear migration during mitotic telophase

GO:1902852
positive regulation of transcription factor import into nucleus in response to oxidative stress

GO:0036283
no_name

GO:0042521
Induced vaginal delivery

HP:0030369
Appendicular hypotonia

HP:0012389
no_name

GO:0042528
neural crest cell fate commitment

GO:0014034
Abnormality of circulating fibrinogen

HP:0011898
regulation of CD4-positive

GO:1900279
obsolete lipoprotein toxin

GO:0015641
5-valerolactone hydrolase activity

GO:0055042
no_name

DOID:13234
Infantile axial hypotonia

HP:0009062
positive regulation of transcription from RNA polymerase II promoter in response to reactive oxygen species

GO:1990095
epithelial cell fate determination

GO:0007425
Premature epimetaphyseal fusion in radius

HP:0012566
mesothelioma malignant recurrent

DOID:6202
negative regulation of ARF protein signal transduction

GO:0032013
Grade I preterm intraventricular hemorrhage

HP:0030748
Reduced plasminogen activator inhibitor 1 antigen

HP:0040249
obsolete beta-glucoside [arbutin-salicin-cellobiose] permease activity

GO:0015583
Reduced aldolase level

HP:0012545
no_name

DOID:12059

Neighbourhood Visualization